A focus on -
DOACs.
Branded generics.
Specialist drugs (Cancer, IMID, MS, Parkinson's, Hep C).
OTCs .
Devices (i.e. Glaucoma).
Sub-cut therapies (IBD).
Oncology and associated homecare products.

Conclusio has been helping organisations access markets and improve their market share for the last decade. Through its experience of leadership in healthcare systems, which spans commissioning, procurement, delivery and monitoring, it understands the essential elements that need to be built into market approaches in the NHS and the wider healthcare industry.